Akso Health Group

Análisis de la acción Akso Health Group (AHG)

$1.270

-0.029 (-2.31%)Al cierre

Loading chart…
Máximo
1.270
Apertura
1.240
Precio medio ponderado por volumen
1.23
Volumen
6.42K
Capitalización
112.36M
Mínimo
1.160
Importe
7.92K
EV/EBITDA, TTM
-32.51

Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace.

Análisis de IA of Akso Health Group (AHG)

Mantener

Currently, Akso Health Group (AHG) is not a strong buy. The stock is trading at $1.30, which is significantly below its 200-day simple moving average of $1.516, indicating a bearish trend. Additionally, the stock has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. While the RSI is at 58.02, indicating potential for upward momentum, the recent 5-day change is -3.70%, reflecting short-term weakness. The main risk is the stock's high price-to-sales ratio of 75.56, which indicates it may be overvalued compared to its sales performance.

Métricas de valoración

El PER previsto actual de Akso Health Group (AHG) es 0.00, frente a su media de 5 años de 0.44.

PER previsto

Infravalorado
Media 5A P/E
0.44
P/E actual
0.00
Sobrevalorada
0.69
Infravalorada
0.20

EV/EBITDA previsto

Infravalorado
Media 5A EV/EBITDA
-8.10
EV/EBITDA actual
-32.51
Sobrevalorada
13.44
Infravalorada
-29.65

Precio/ventas previsto

Sobrevalorado
Media 5A P/S
3.73
P/S actual
11.26
Sobrevalorada
8.65
Infravalorada
-1.19

Escenarios de precio de Alphio AI para AHG

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%AHG

$2.52

Precio del escenario

B

Base

Base · 50%AHG

$2.26

Precio del escenario

B

Bajista

Bajista · 25%AHG

$2.01

Precio del escenario

Preguntas frecuentes sobre AHG, respondidas por Alphio AI

Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).

Currently, Akso Health Group (AHG) is not a strong buy. The stock is trading at $1.30, which is significantly below its 200-day simple moving average of $1.516, indicating a bearish trend. Additionally, the stock has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. While the RSI is at 58.02, indicating potential for upward momentum, the recent 5-day change is -3.70%, reflecting short-term weakness. The main risk is the stock's high price-to-sales ratio of 75.56, which indicates it may be overvalued compared to its sales performance.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar